Xylem Inc. (XYL) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.49%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.58%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.49% | Research and development expense / revenue. Period ending 2026-06-30. $227.00M ÷ $9.13B × 100 ≈ 2.49% |
| Stock-based compensation / revenue · 12 months | 0.58% | Share-based compensation / revenue. Period ending 2026-06-30. $53.00M ÷ $9.13B × 100 ≈ 0.58% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 227.00M USD | Research and Development Expense |
| Revenue | 9.13B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 53.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.32B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $227.00M | $9.13B | $53.00M | $1.32B | (m) | 2.49% | 0.58% | (m) | (m) |
| 2026-03-31 | $226.00M | $9.09B | $54.00M | $1.24B | (m) | 2.49% | 0.59% | (m) | (m) |
| 2025-12-31 | $226.00M | $9.04B | $53.00M | $1.22B | (m) | 2.50% | 0.59% | (m) | (m) |
| 2025-09-30 | $224.00M | $8.89B | $50.00M | $1.14B | (m) | 2.52% | 0.56% | (m) | (m) |
| 2025-06-30 | $227.00M | $8.73B | $50.00M | $1.08B | (m) | 2.60% | 0.57% | (m) | (m) |
| 2025-03-31 | $227.00M | $8.60B | $50.00M | $1.03B | (m) | 2.64% | 0.58% | (m) | (m) |
| 2024-12-31 | $230.00M | $8.56B | $56.00M | $1.01B | (m) | 2.69% | 0.65% | (m) | (m) |
| 2024-09-30 | $232.00M | $8.42B | $58.00M | $953.00M | $49.00M | 2.75% | 0.69% | 19.45× | Reported |
| 2024-06-30 | $238.00M | $8.40B | $64.00M | $864.00M | $53.00M | 2.83% | 0.76% | 16.30× | Reported |
| 2024-03-31 | $238.00M | $7.95B | $66.00M | $730.00M | $54.00M | 2.99% | 0.83% | 13.52× | Reported |
| 2023-12-31 | $232.00M | $7.36B | $60.00M | $652.00M | $49.00M | 3.15% | 0.81% | 13.31× | Reported |
| 2023-09-30 | $226.00M | $6.75B | $54.00M | $638.00M | $48.00M | 3.35% | 0.80% | 13.29× | Reported |
| 2023-06-30 | $212.00M | $6.06B | $46.00M | $615.00M | $46.00M | 3.50% | 0.76% | 13.37× | Reported |
| 2023-03-31 | $207.00M | $5.70B | $40.00M | $642.00M | $46.00M | 3.63% | 0.70% | 13.96× | Reported |
| 2022-12-31 | $206.00M | $5.52B | $37.00M | $622.00M | $50.00M | 3.73% | 0.67% | 12.44× | Reported |
| 2022-09-30 | $204.00M | $5.34B | $36.00M | $565.00M | $50.00M | 3.82% | 0.67% | 11.30× | Reported |
| 2022-06-30 | $206.00M | $5.22B | $34.00M | $549.00M | $59.00M | 3.94% | 0.65% | 9.31× | Reported |
| 2022-03-31 | $206.00M | $5.21B | $33.00M | $563.00M | $68.00M | 3.95% | 0.63% | 8.28× | Reported |
| 2021-12-31 | $204.00M | $5.20B | $33.00M | $585.00M | $76.00M | 3.93% | 0.64% | 7.70× | Reported |
| 2021-09-30 | $201.00M | $5.25B | $32.00M | $624.00M | $84.00M | 3.83% | 0.61% | 7.43× | Reported |
| 2021-06-30 | $197.00M | $5.20B | $27.00M | $545.00M | $85.00M | 3.79% | 0.52% | 6.41× | Reported |
| 2021-03-31 | $188.00M | $5.01B | $27.00M | $439.00M | $82.00M | 3.75% | 0.54% | 5.35× | Reported |
| 2020-12-31 | $187.00M | $4.88B | $26.00M | $367.00M | $77.00M | 3.84% | 0.53% | 4.77× | Reported |
| 2020-09-30 | $187.00M | $4.87B | $25.00M | $383.00M | $71.00M | 3.84% | 0.51% | 5.39× | Reported |
| 2020-06-30 | $186.00M | $4.95B | $29.00M | $321.00M | $65.00M | 3.76% | 0.59% | 4.94× | Reported |
| 2020-03-31 | $189.00M | $5.13B | $28.00M | $438.00M | $65.00M | 3.68% | 0.55% | 6.74× | Reported |
| 2019-12-31 | $191.00M | $5.25B | $29.00M | $486.00M | $67.00M | 3.64% | 0.55% | 7.25× | Reported |
| 2019-09-30 | $194.00M | $5.26B | $30.00M | $485.00M | $71.00M | 3.69% | 0.57% | 6.83× | Reported |
| 2019-06-30 | $196.00M | $5.25B | $30.00M | $650.00M | $76.00M | 3.73% | 0.57% | 8.55× | Reported |
| 2019-03-31 | $199.00M | $5.23B | $30.00M | $650.00M | $79.00M | 3.81% | 0.57% | 8.23× | Reported |
| 2018-12-31 | $189.00M | $5.21B | $30.00M | $654.00M | $82.00M | 3.63% | 0.58% | 7.98× | Reported |
| 2018-09-30 | $186.00M | $5.10B | $28.00M | $641.00M | $83.00M | 3.65% | 0.55% | 7.72× | Reported |
| 2018-06-30 | $185.00M | $5.01B | $26.00M | $617.00M | $83.00M | 3.70% | 0.52% | 7.43× | Reported |
| 2018-03-31 | $179.00M | $4.85B | $24.00M | $583.00M | $83.00M | 3.69% | 0.49% | 7.02× | Reported |
| 2017-12-31 | $180.00M | $4.71B | $21.00M | $556.00M | $82.00M | 3.82% | 0.45% | 6.78× | Reported |
| 2017-09-30 | $166.00M | $4.53B | $19.00M | $486.00M | $82.00M | 3.67% | 0.42% | 5.93× | Reported |
| 2017-06-30 | $144.00M | $4.23B | $19.00M | $443.00M | $77.00M | 3.41% | 0.45% | 5.75× | Reported |
| 2017-03-31 | $127.00M | $4.00B | $19.00M | $413.00M | $76.00M | 3.18% | 0.48% | 5.43× | Reported |
| 2016-12-31 | $110.00M | $3.77B | $18.00M | $406.00M | $70.00M | 2.92% | 0.48% | 5.80× | Reported |
| 2016-09-30 | $99.00M | $3.67B | $19.00M | $439.00M | $64.00M | 2.70% | 0.52% | 6.86× | Reported |
| 2016-06-30 | $99.00M | $3.67B | $17.00M | $450.00M | $61.00M | 2.69% | 0.46% | 7.38× | Reported |
| 2016-03-31 | $97.00M | $3.66B | $16.00M | $445.00M | $55.00M | 2.65% | 0.44% | 8.09× | Reported |
| 2015-12-31 | $95.00M | $3.65B | $15.00M | $449.00M | $55.00M | 2.60% | 0.41% | 8.16× | Reported |
| 2015-09-30 | $97.00M | $3.70B | $15.00M | $448.00M | $54.00M | 2.62% | 0.41% | 8.30× | Reported |
| 2015-06-30 | $98.00M | (m) | $17.00M | $458.00M | $55.00M | (m) | (m) | 8.33× | Reported |
| 2015-03-31 | $100.00M | $3.85B | $18.00M | $470.00M | $54.00M | 2.60% | 0.47% | 8.70× | Reported |
| 2014-12-31 | $104.00M | $3.92B | $18.00M | $463.00M | $54.00M | 2.66% | 0.46% | 8.57× | Reported |
| 2014-09-30 | $104.00M | $3.91B | $20.00M | $451.00M | $55.00M | 2.66% | 0.51% | 8.20× | Reported |
| 2014-06-30 | $104.00M | (m) | $24.00M | $419.00M | $55.00M | (m) | (m) | 7.62× | Reported |
| 2014-03-31 | $105.00M | $3.86B | $25.00M | $373.00M | $56.00M | 2.72% | 0.65% | 6.66× | Reported |
| 2013-12-31 | $104.00M | $3.84B | $27.00M | $363.00M | $55.00M | 2.71% | 0.70% | 6.60× | Reported |
| 2013-09-30 | $104.00M | $3.77B | $27.00M | $338.00M | $55.00M | 2.76% | 0.72% | 6.15× | Reported |
| 2013-06-30 | $104.00M | $3.74B | $24.00M | $351.00M | $55.00M | 2.78% | 0.64% | 6.38× | Reported |
| 2013-03-31 | $104.00M | $3.75B | $23.00M | $410.00M | $54.00M | 2.78% | 0.61% | 7.59× | Reported |
| 2012-12-31 | $106.00M | $3.79B | $22.00M | $443.00M | $55.00M | 2.80% | 0.58% | 8.05× | Reported |
| 2012-09-30 | $107.00M | $3.83B | $22.00M | $438.00M | $56.00M | 2.80% | 0.58% | 7.82× | Reported |
| 2012-06-30 | $106.00M | $3.83B | $18.00M | $407.00M | $43.00M | 2.77% | 0.47% | 9.47× | Reported |
| 2012-03-31 | $104.00M | $3.84B | $15.00M | $394.00M | (m) | 2.71% | 0.39% | (m) | (m) |
| 2011-12-31 | $100.00M | $3.80B | $13.00M | $395.00M | $17.00M | 2.63% | 0.34% | 23.24× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $74.00M | $3.20B | $9.00M | $388.00M | (m) | 2.31% | 0.28% | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $63.00M | $2.85B | $9.00M | $276.00M | (m) | 2.21% | 0.32% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ITT INC. (ITT) | United States | $19.129B | 39.62 |
| IDEX CORP /DE/ (IEX) | United States | $16.848B | 32.33 |
| GRACO INC (GGG) | United States | $12.488B | 23.77 |
| FLOWSERVE CORP (FLS) | United States | $9.667B | 25.54 |
| GORMAN RUPP CO (GRC) | United States | $1.969B | 38.90 |
| AMPCO PITTSBURGH CORP (AP) | United States | $0.179B | -3.00 |